CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling
Authors:
Open Access
- 10 June 2018
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2018, 1-13
Abstract
Chronic obstructive pulmonary disease (COPD) is one of the common and underdiagnosed diseases with the highest morbidity and mortality in the world. The development of COPD can lead to pulmonary vascular remodeling and pulmonary hypertension, further causing the occurrence of pulmonary heart disease. Therefore, attenuation of pulmonary vascular remodeling and pulmonary hypertension caused by COPD can significantly delay cardiovascular complications. In the study, we firstly found that the expression of CD30 and CD30L was increased in COPD. Importantly, the serum CD30L levels were significantly higher in patients with stable COPD relative to those with acute exacerbation of COPD (AECOPD). This suggested that CD30 might be related to the development of COPD. In addition, we found that the expression of CD30 in the COPD rat model was significantly increased compared with control group. And treatment with the anti-CD30 antibody reduced the serum concentration and tissue expression of CD30 in rat. Importantly, anti-CD30 antibody alleviated pulmonary vascular remodeling in COPD model rats. This suggested that CD30 played an important role in the course of COPD. Finally, we found that, in the HPASMC and HPAEC cell lines, CD30 can affect the cell viability and cell migration and inhibited hypoxia-induced cell apoptosis in a concentration-dependent manner. We also found CD30 induced extracellular matrix formation through decreasing the expression of MMP-2, thus promoting the pulmonary vascular remodeling. The study indicated that CD30 and CD30L were involved in pulmonary vascular remodeling and inflammatory response in COPD. Altogether, CD30 might be a marker for the early diagnosis and progression of COPD.Keywords
This publication has 47 references indexed in Scilit:
- The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary diseasePulmonary Circulation, 2017
- Long-acting Inhaled Bronchodilator and Risk of Vascular Events in Patients With Chronic Obstructive Pulmonary Disease in Taiwan PopulationMedicine, 2015
- Comparing four different ALK antibodies with manual immunohistochemistry (IHC) to screen for ALK -rearranged non-small cell lung cancer (NSCLC)Lung Cancer, 2015
- Mesenchymal stem cells protect cigarette smoke‐damaged lung and pulmonary function partly via VEGF–VEGF receptorsJournal of Cellular Biochemistry, 2012
- Expression of CD30 antigen in superficial mycotic infections of the skin: a possible non-specific finding without clinical relevanceMycoses, 2010
- Increased intraepithelial T-cells in stable COPDRespiratory Medicine, 2008
- Direct evidence for a critical role of CD30 in the development of allergic asthmaJournal of Allergy and Clinical Immunology, 2006
- Hypoxia and hypoxia-inducible factor-1α promote growth factor-induced proliferation of human vascular smooth muscle cellsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Robo family of proteins exhibit differential expression in mouse spinal cord and Robo–Slit interaction is required for midline crossing in vertebrate spinal cordDevelopmental Dynamics, 2005
- Up-Regulation of Interleukin-8 by Novel Small Cytoplasmic Molecules of NontypeableHaemophilus influenzaevia p38 and Extracellular Signal-Regulated Kinase PathwaysInfection and Immunity, 2003